Semaglutide vs Retatrutide UK — GLP-1 vs Triple Agonist Research Comparison
Semaglutide is a selective GLP-1 receptor agonist; retatrutide is a triple GLP-1/GIP/glucagon receptor agonist. This comparison breaks down the receptor profiles, research applications, and when to choose each compound for your metabolic research study as one of the highest purity peptides.
Semaglutide 30mg
GLP-1 receptor agonist — 30mg lyophilised research compound. Lab-verified, 99%+ purity.
Retatrutide 30mg
Triple agonist (GLP-1/GIP/Glucagon) — 30mg research compound. Lab-verified, 99%+ purity.
Detailed comparison
Lab-Verified Purity
Every batch independently tested with published COAs.
Published COAs
Certificates of Analysis available on every product page.
Research Use Only
For laboratory research. Not for human or animal use.
Frequently asked questions
Related reading
Ready to compare semaglutide and retatrutide?
Both compounds lab-verified, independently tested, and shipped discreetly from the UK.
Shop NowResearch Use Only — Strictly Not for Human or Animal Use
All compounds sold by HPLC Peps are supplied exclusively for professional in vitro laboratory research. They are not medicines, not licensed for any diagnostic or therapeutic application, and must not be administered to humans or animals under any circumstances. The purchaser assumes full responsibility for safe handling, storage, and regulatory compliance. HPLC Peps accepts no liability for misuse.